Abstract
Desmin mutations underlie inherited myopathies/cardiomyopathies with varying severity and involvement of the skeletal and cardiac muscles. We developed a transgenic mouse model expressing low level of the L345P desmin mutation (DESMUT mice) in order to uncover changes in skeletal and cardiac muscles caused by this mutation. The most striking ultrastructural changes in muscle from DESMUT mice were mitochondrial swelling and vacuolization. The mitochondrial Ca2+ level was significantly increased in skeletal and cardiac myocytes from DESMUT mice compared to wild type cells during and after contractions. In isolated DESMUT soleus muscles, contractile function and recovery from fatigue were impaired. A SHIRPA screening test for neuromuscular performance demonstrated decreased motor function in DESMUT compared to WT mice. Echocardiographic changes in DESMUT mice included left ventricular wall hypertrophy and a decreased left ventricular chamber dimension. The results imply that low levels of L345P desmin acts, at least partially, by a dominant negative effect on mitochondria.
Similar content being viewed by others
Abbreviations
- DESMUT:
-
Mice transgenic with L345P mutated desmin
- WT:
-
Wild type mice
References
Bär H, Mucke N, Kostareva A et al (2005) Severe muscle disease-causing desmin mutations interfere with in vitro filament assembly at distinct stages. Proc Natl Acad Sci USA 102:15099–15104. doi:10.1073/pnas.0504568102
Bär H, Kostareva A, Sjoberg G et al (2006a) Forced expression of desmin and desmin mutants in cultured cells: impact of myopathic missense mutations in the central coiled-coil domain on network formation. Exp Cell Res 312:1554–1565. doi:10.1016/j.yexcr.2006.01.021
Bär H, Mucke N, Ringler P et al (2006b) Impact of disease mutations on the desmin filament assembly process. J Mol Biol 360:1031–1042. doi:10.1016/j.jmb.2006.05.068
Barohn RJ (1993) Distal myopathies and dystrophies. Semin Neurol 13:247–255
Belluardo N, Westerblad H, Mudo G et al (2001) Neuromuscular junction disassembly and muscle fatigue in mice lacking neurotrophin-4. Mol Cell Neurosci 18:56–67. doi:10.1006/mcne.2001.1001
Bernardi P (1999) Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol Rev 79:1127–1155
Brookes PS, Yoon Y, Robotham JL et al (2004) Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 287:C817–C833. doi:10.1152/ajpcell.00139.2004
Bruton J, Tavi P, Aydin J et al (2003) Mitochondrial and myoplasmic [Ca2+] in single fibres from mouse limb muscles during repeated tetanic contractions. J Physiol 551:179–190. doi:10.1113/jphysiol.2003.043927
Capetanaki Y (2002) Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function. Trends Cardiovasc Med 12:339–348. doi:10.1016/S1050-1738(02)00184-6
Carlsson L, Fischer C, Sjoberg G et al (2002) Cytoskeletal derangements in hereditary myopathy with a desmin L345P mutation. Acta Neuropathol 104:493–504
Chen F, Chang R, Trivedi M et al (2003) Caspase proteolysis of desmin produces a dominant-negative inhibitor of intermediate filaments and promotes apoptosis. J Biol Chem 278:6848–6853. doi:10.1074/jbc.M212021200
David G, Barrett JN, Barrett EF (1998) Evidence that mitochondria buffer physiological Ca2+ loads in lizard motor nerve terminals. J Physiol 509(Pt 1):59–65. doi:10.1111/j.1469-7793.1998.059bo.x
Duchen MR, Leyssens A, Crompton M (1998) Transient mitochondrial depolarizations reflect focal sarcoplasmic reticular calcium release in single rat cardiomyocytes. J Cell Biol 142:975–988. doi:10.1083/jcb.142.4.975
Esposito LA, Melov S, Panov A et al (1999) Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci USA 96:4820–4825. doi:10.1073/pnas.96.9.4820
Fauconnier J, Lanner JT, Zhang SJ et al (2005) Insulin and inositol 1,4,5-trisphosphate trigger abnormal cytosolic Ca2+ transients and reveal mitochondrial Ca2+ handling defects in cardiomyocytes of ob/ob mice. Diabetes 54:2375–2381. doi:10.2337/diabetes.54.8.2375
Fidzianska A, Drac H, Kaminska AM (1999) Familial inclusion body myopathy with desmin storage. Acta Neuropathol 97:509–514. doi:10.1007/s004010051021
Fidzianska A, Kotowicz J, Sadowska M et al (2005) A novel desmin R355P mutation causes cardiac and skeletal myopathy. Neuromuscul Disord 15:525–531. doi:10.1016/j.nmd.2005.05.006
Fountoulakis M, Soumaka E, Rapti K et al (2005) Alterations in the heart mitochondrial proteome in a desmin null heart failure model. J Mol Cell Cardiol 38:461–474. doi:10.1016/j.yjmcc.2004.12.008
Gao J, Li Z, Paulin D (1998) A novel site, Mt, in the human desmin enhancer is necessary for maximal expression in skeletal muscle. J Biol Chem 273:6402–6409. doi:10.1074/jbc.273.11.6402
Goldfarb LG, Vicart P, Goebel HH et al (2004) Desmin myopathy. Brain 127:723–734. doi:10.1093/brain/awh033
Herrmann H, Strelkov SV, Feja B et al (2000) The intermediate filament protein consensus motif of helix 2B: its atomic structure and contribution to assembly. J Mol Biol 298:817–832. doi:10.1006/jmbi.2000.3719
Ingber DE (1997) Tensegrity: the architectural basis of cellular mechanotransduction. Annu Rev Physiol 59:575–599. doi:10.1146/annurev.physiol.59.1.575
Kay L, Li Z, Mericskay M et al (1997) Study of regulation of mitochondrial respiration in vivo. An analysis of influence of ADP diffusion and possible role of cytoskeleton. Biochim Biophys Acta 1322:41–59. doi:10.1016/S0005-2728(97)00071-6
Lännergren J, Westerblad H, Bruton JD (2001) Changes in mitochondrial Ca2+ detected with Rhod-2 in single frog and mouse skeletal muscle fibres during and after repeated tetanic contractions. J Muscle Res Cell Motil 22:265–275. doi:10.1023/A:1012227009544
Lazarides E (1980) Desmin and intermediate filaments in muscle cells. Results Probl Cell Differ 11:124–131
Lazarides E (1982) Intermediate filaments: a chemically heterogeneous, developmentally regulated class of proteins. Annu Rev Biochem 51:219–250. doi:10.1146/annurev.bi.51.070182.001251
Li Z, Marchand P, Humbert J et al (1993) Desmin sequence elements regulating skeletal muscle-specific expression in transgenic mice. Development 117:947–959
Li D, Tapscoft T, Gonzalez O et al (1999) Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100:461–464
Linden M, Li Z, Paulin D et al (2001) Effects of desmin gene knockout on mice heart mitochondria. J Bioenerg Biomembr 33:333–341. doi:10.1023/A:1010611408007
Mericskay M, Li Z, Paulin D (1999) Transcriptional regulation of the desmin and SM22 genes in vascular smooth muscle cells. Curr Top Pathol 93:7–17
Mericskay M, Parlakian A, Porteu A et al (2000) An overlapping CArG/octamer element is required for regulation of desmin gene transcription in arterial smooth muscle cells. Dev Biol 226:192–208. doi:10.1006/dbio.2000.9865
Milner DJ, Mavroidis M, Weisleder N et al (2000) Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J Cell Biol 150:1283–1298. doi:10.1083/jcb.150.6.1283
Munoz-Marmol AM, Strasser G, Isamat M et al (1998) A dysfunctional desmin mutation in a patient with severe generalized myopathy. Proc Natl Acad Sci USA 95:11312–11317. doi:10.1073/pnas.95.19.11312
Rafael JA, Nitta Y, Peters J et al (2000) Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice. Mamm Genome 11:725–728. doi:10.1007/s003350010149
Rappaport L, Oliviero P, Samuel JL (1998) Cytoskeleton and mitochondrial morphology and function. Mol Cell Biochem 184:101–105. doi:10.1023/A:1006843113166
Reipert S, Steinbock F, Fischer I et al (1999) Association of mitochondria with plectin and desmin intermediate filaments in striated muscle. Exp Cell Res 252:479–491. doi:10.1006/excr.1999.4626
Russell LK, Finck BN, Kelly DP (2005) Mouse models of mitochondrial dysfunction and heart failure. J Mol Cell Cardiol 38:81–91. doi:10.1016/j.yjmcc.2004.10.010
Saks VA, Kuznetsov AV, Khuchua ZA et al (1995) Control of cellular respiration in vivo by mitochondrial outer membrane and by creatine kinase. A new speculative hypothesis: possible involvement of mitochondrial–cytoskeleton interactions. J Mol Cell Cardiol 27:625–645. doi:10.1016/S0022-2828(08)80056-9
Sjöberg G, Saavedra-Matiz CA, Rosen DR et al (1999) A missense mutation in the desmin rod domain is associated with autosomal dominant distal myopathy, and exerts a dominant negative effect on filament formation. Hum Mol Genet 8:2191–2198. doi:10.1093/hmg/8.12.2191
Strelkov SV, Herrmann H, Geisler N et al (2002) Conserved segments 1A and 2B of the intermediate filament dimer: their atomic structures and role in filament assembly. EMBO J 21:1255–1266. doi:10.1093/emboj/21.6.1255
Sugawara M, Kato K, Komatsu M et al (2000) A novel de novo mutation in the desmin gene causes desmin myopathy with toxic aggregates. Neurology 55:986–990
Wang X, Osinska H, Dorn GW et al (2001) Mouse model of desmin-related cardiomyopathy. Circulation 103:2402–2407
Ye G, Metreveli NS, Donthi RV et al (2004) Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 53:1336–1343. doi:10.2337/diabetes.53.5.1336
Acknowledgements
We acknowledge the skilled technical assistance of Ann-Christin Thelander. This work was supported by the Swedish Heart-Lung foundation, Stiftelsen Frimurare Barnhuset, King Gustav V and Queen Victoria foundation, Sällskapet Barnavård, Stiftelsen Samariten, Ronald MacDonald Child Fund, Sunnerdahls Handikappfond, Swedish Research Council and Swedish Institute (KIRT program), and United Mitochondrial Disease Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kostareva, A., Sjöberg, G., Bruton, J. et al. Mice expressing L345P mutant desmin exhibit morphological and functional changes of skeletal and cardiac mitochondria. J Muscle Res Cell Motil 29, 25–36 (2008). https://doi.org/10.1007/s10974-008-9139-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10974-008-9139-8